For example, shifts in mitochondrial metabolism are well established for cancer cells and are accompanied by ectopic expression of olfactomedin 4 (OLFM4), a marker for actively cycling ISCs that also labels a subset of CRC cells (van der Flier et al., 2009; Ashizawa et al., 2019). This evidence concerns the gene OLFM4 and colorectal carcinoma.